Royalty Pharma plc

NASDAQ (USD): Royalty Pharma plc (RPRX)

Last Price

25.40

Today's Change

+0.17 (0.67%)

Day's Change

25.16 - 25.46

Trading Volume

1,447,310

Overview

Market Cap

11 Billion

Shares Outstanding

444 Million

Avg Volume

2,749,377

Avg Price (50 Days)

26.35

Avg Price (200 Days)

27.54

PE Ratio

10.00

EPS

2.54

Earnings Announcement

13-Feb-2025

Previous Close

25.23

Open

25.19

Day's Range

25.16 - 25.46

Year Range

24.05 - 31.655

Trading Volume

1,448,760

Price Change Highlight

1 Day Change

0.67%

5 Day Change

4.35%

1 Month Change

-3.39%

3 Month Change

-9.90%

6 Month Change

-4.44%

Ytd Change

-10.15%

1 Year Change

-6.75%

3 Year Change

-36.71%

5 Year Change

-42.92%

10 Year Change

-42.92%

Max Change

-42.92%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment